Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Toxicology

Volumn 181-182, Issue , 2002, Pages 577-580

  Nortier, J L ^a   Vanherweghem, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Aristolochia species; Aristolochic acids; Herbal remedies; Nephrotoxicity; Renal fibrosis; Urothelial carcinoma

Indexed keywords

PLANT TOXIN;

ARISTOLOCHIA FANGCHI; CANCER RISK; CHINA; HERBAL MEDICINE; HUMAN; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; MEDICINAL PLANT; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; UROGENITAL TRACT CANCER;

AKEBIA; ARISTOLOCHIA; ARISTOLOCHIA FANGCHI; ASARUM; CLEMATIS; COCCULUS; STEPHANIA TETRANDRA;

EID: 0037184789     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00486-9     Document Type: Article

References (18)

1. Bieler C.A., et al. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis. 18:1997;1063-1067.
2. Bostwick D.G., Eble J.N. Urologic Surgical Pathology. 1997;246-247 Mosby-Year Book, St Louis.
3. Cabanne F., Pagès A., Billerey C., Oppermann A., Carbillet J.-P. Pathologie génitale masculine: uropathologie. 1992;354-355 Masson, Paris.
4. Depierreux M., et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24:1994;172-180.
5. European Agency for the Evaluation of Medicinal Products. Document EMEA/HMPWP/23/00, October 2000.
6. Mengs U., et al. The carcinogenic action of aristolochic acid in rats. Arch. Toxicol. 51:1982;107-119.
7. Murphy W.M., Soloway M.S. Urothelial dysplasia. J. Urol. 127:1982;849-854.
8. Nortier J., et al. Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria. Kidney Int. 51:1997;288-293.
9. Nortier J., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New Engl. J. Med. 342:2000;1686-1692.
10. Pezzuto J.M., et al. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. Mut. Res. 206:1988;447-454.
11. Richards B., et al. Interpretation of biopsies of 'normal' urothelium in patients with superficial bladder cancer. Br. J. Urol. 67:1991;369-375.
12. Schmeiser H.H., et al. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis. 7:1986;59-63.
13. Schmeiser H.H., et al. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56:1996;2025-2028.
14. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumors. Fifth Ed. 1997;Wiley-Liss, New York.
15. US Food and Drug Administration Center for Food Safety and Applied Nutrition. Office of Nutritional Products, Labeling, and Dietary Supplements. Revised version May 30, 2000.
16. Vanhaelen M., et al. Identification of aristolochic acid in Chinese herbs. Lancet. 343:1994;174.
17. Vanherweghem J.-L., et al. Rapidly progressive intersitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 341:1993;387-391.
18. Vanherweghem J.-L. Nephropathy and herbal medicine. Am. J. Kidney Dis. 35:2000;330-332.